Isoprostanes, a marker of lipid peroxidation, may not be involved in the development of glucose intolerance

Diabetes Research and Clinical Practice

Volumn 76, Issue 1, 2007, Pages 149-151

  Boyne, Michael S ^a   Sargeant, Lincoln A ^a   Bennett, Franklyn I ^a   Wilks, Rainford J ^a   Cooper, Richard S ^b   Forrester, Terrence E ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Beta cell function; Impaired glucose tolerance; Isoprostanes; Oxidative stress

Indexed keywords

ISOPROSTANE;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CASE CONTROL STUDY; CELL FUNCTION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; KIDNEY CONCENTRATING CAPACITY; LIPID PEROXIDATION; MULTIPLE REGRESSION;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; COHORT STUDIES; FASTING; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISOPROSTANES; JAMAICA; LIPID PEROXIDATION; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; URBAN POPULATION;

EID: 33846929639     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.08.003     Document Type: Article

References (10)

1. Baynes J.W., and Thorpe S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48 (1999) 1-9
2. Miwa I., Ichimura N., Sugiura M., Hamada Y., and Taniguchi S. Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 141 (2000) 2767-2772
3. Morrow J.D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 279-286
4. Davi G., Ciabattoni G., Consoli A., Mezzetti A., Falco A., Santarone S., et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and Vitamin E supplementation. Circulation 99 (1999) 224-229
5. Mezzetti A., Cipollone F., and Cuccurullo F. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm. Cardiovasc. Res. 47 (2000) 475-488
6. Sargeant L.A., Boyne M.S., Bennett F.I., Forrester T.E., Cooper R.S., and Wilks R.J. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?. Rev. Panam. Salud. Publica 16 (2004) 35-42
7. Boyne M.S., Gaskin P., Luke A., Wilks R.J., Bennett F.I., Younger N., et al. Energetic determinants of glucose tolerance status in Jamaican adults. Eur. J. Clin. Nutr. 58 (2004) 1666-1668
8. Ataman S.L., Cooper R., Rotimi C., McGee D., Osotimehin B., Kadiri S., et al. Standardization of blood pressure measurement in an international comparative study. J. Clin. Epidemiol. 49 (1996) 869-877
9. Gopaul N.K., Manraj M.D., Hebe A., Lee Kwai Yan S., Johnston A., Carrier M.J., et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 44 (2001) 706-712
10. Il'yasova D., Morrow J.D., and Wagenknecht L.E. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes. Res. 13 (2005) 1638-1644